Cerus | CERS - Stammkapital





Stammkapital Veränderung Datum
GRIFOLS EUR 680.58M 0 2026-09
Haemonetics USD 45.52M 53K 2026-09
Neogen USD 218.3M 600K 2026-06
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 275K 138.4M 2026-03
Quidel USD 68.3M 200K 2026-06
STAAR Surgical USD 50.2M 78K 2026-09
Terumo JPY 1.48B 19K 2026-06
Utah Medical Products USD 3.18M 2K 2026-03